Celebrate 20 years of Malecare Prostate Cancer Support Groups., at a special two hour discussion with three of NYC"s top cancer doctors. Your questions will be welcome! Dr. Kelly Cassano, Senior Associate Dean for Clinical Affairs, Chief of Ambulatory Care at Mount Sinai Downtown William K. Oh, MD, Medical Oncologist and Robert Stewart, MD, Radiation [...]
What view or place or sounds makes you feel most relaxed? Can you make a one to three minute video of that? For me, it's standing in the ocean, water lapping my ankles, listening to distant waves breaking. For my father, it was watching horses at riding academy in The Bronx, NY. What view chills [...]
Taking care of a loved one can be a rewarding but stressful experience. You may feel that you are the best equipped to handle the situation, or financial concerns may have prodded you unwittingly into the caregiver role. No matter how prepared you may be for the job, caregiver stress can plague anyone. This [...]
Being told that you have prostate cancer may be one of the most stressful events that occur in your lifetime. After a cancer diagnosis, you may be overwhelmed, worried about what happens next, or thinking about its impact on your life. The many emotions that follow a prostate cancer diagnosis make a major impression [...]
Prostate cancer patients struggle to ask all of their questions. Men often leave their doctor's offices with one or more unanswered question...."I forgot to ask." Even with lists of questions written out in advance, patients skip over one or more questions or simply fail to give voice to things that trouble them the [...]
Non-metastatic Castrate Resistant prostate cancer patients take note. The Phase 3 PROSPER trial in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC) showed that the use of XTANDI® (enzalutamide) plus androgen deprivation therapy (ADT) significantly reduced the risk of developing metastases or death by 71 percent compared to ADT alone. It will be a [...]
Present. It's where we live. Where we exist. Moment to moment. Not measured by the ticking of the clock. Only measured if we live in the moment...exist, now. Be here, now. We practice for many moments, hours, days, years and then we arrive here, now, in the present. And then, cancer arrives in our [...]
Prostate cancer tends to metastasize to bones as opposed to soft tissue and other organs. We have no idea why it does have a preference for bone, but it does. Developing bone metastases in prostrate cancer is a very strong negative prognostic indicator. Prostate cancer’s tendency to favor bone over soft tissue causes significant morbidity [...]
We know that men with metastatic castration-resistant prostate cancer (mCRPC) and visceral metastases have a worse prognosis than those with non-visceral metastases. The important question we need to understand is what, of our currently available treatments, might be effective for this more aggressive and deadly type of prostate cancer? Results of the phase 3 AFFIRM [...]
Being able to make better decisions about drug sequencing and combinations has become one of the current hot topics in prostate cancer research. Given that we have a number of newer drugs to use this is an important clinical issue as we make important treatment decisions. Making these clinical decisions is tough. The fact is [...]